000 | 01896na a2200217 4500 | ||
---|---|---|---|
999 |
_c780 _d780 |
||
003 | PC780 | ||
005 | 20190730133147.0 | ||
008 | 130622s2013 xxx||||| |||| 00| 0 eng d | ||
040 | _cH12O | ||
041 | _aspa | ||
100 |
_aBenito León, Julián _9892 _eNeurología |
||
100 |
_aPozuelo Moyano, Beatriz _92575 _eNeurología |
||
245 | 0 | 0 |
_aVitamina D y esclerosis múltiple. _h[artículo] |
260 |
_bRevista de neurología, _c2013 |
||
300 | _a56(4):243-51. | ||
500 | _aFormato Vancouver: Pozuelo-Moyano B, Benito-León J. Vitamina D y esclerosis múltiple. Rev Neurol 2013; 56: 243-51. | ||
501 | _aPMID: 23400652 | ||
504 | _aContiene 79 referencias | ||
520 | _aINTRODUCTION: The main effects of vitamin D have to do with the homeostasis of calcium and phosphorous, and also with the regulation of bone remodelling. Yet, in recent years, different lines of research have given rise to a large body of knowledge about its role in the pathogenesis and the treatment of multiple sclerosis (MS). AIM. To carry out a critical review of the evidence that relates vitamin D with MS from an epidemiological, genetic, immunological and therapeutic point of view. | ||
710 |
_9267 _aServicio de Neurología-Neurofisiología |
||
856 |
_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/7/pc780.pdf _ySolicitar documento |
||
942 |
_n0 _2ddc _cART |